This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MAJ Douglas J. Harben, MC; MAJ Philip H. Cooper, MC; COL Orlando G. Rodman, MC

Arch Dermatol. 1979;115(8):973-974.

Abstract
Periorbital depigmentation developed in a black man approximately six months after the application of an ophthalmic solution containing thiotepa. The drug was used postoperatively to prevent revascularization after removal of a pterygium. By light and electron microscopy, melanocytes were apparently absent in the depigmented area. The list of medications and chemicals that can cause cutaneous depigmentation is growing. An appropriate history may be of considerable value in the evaluation of vitiligo-like conditions.

(Arch Dermatol 115:973-974, 1979)

Author Affiliations
USAR; USAR; USA

From the Department of Medicine, Dermatology Service, Walter Reed Army Medical Center (Drs Harben and Rodman), and the Department of Skin and Gastrointestinal Pathology, Armed Forces Institute of Pathology (Dr Cooper), Washington, DC. Dr Cooper is now with the Departments of Pathology and Dermatology, University of Virginia, Charlottesville.

Footnotes
Accepted for publication Feb 26, 1979.

The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.

Reprint requests to Dermatology Service, Department of Medicine, Walter Reed Army Medical Center, Washington, DC 20012 (Dr Rodman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?